Clinical Trial Update: Zinc Supplements in Lowering Cadmium Levels in Smokers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluated zinc supplementation to lower cadmium levels in smokers; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cervical Cancer
• Esophageal Cancer
• Gastric Cancer
• Head and Neck Cancer
• Kidney Cancer
• Leukemia
• Liver Cancer

Drugs mentioned

• Zinc supplement (zinc)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Bladder Cancer, Cervical Cancer | Phase 2 | Status: COMPLETED